Suppression of the onset and progression of collagen-induced arthritis in rats by QFGJS, a preparation from an anti-arthritic Chinese herbal formula

Journal of Ethnopharmacology

Volumn 110, Issue 1, 2007, Pages 39-48

  Cai, Xiong ^a   Zhou, Hua ^a   Wong, Yuen Fan ^a   Xie, Ying ^a   Liu, Zhong Qiu ^a   Jiang, Zhi Hong ^a   Bian, Zhao Xiang ^a   Xu, Hong Xi ^b   Liu, Liang ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anti arthritis; Collagen induced arthritis; Herbal medicine; Pro inflammatory cytokines; QFGJS; Rheumatoid arthritis

Indexed keywords

ACONITUM EXTRACT; ANTIRHEUMATIC AGENT; COLLAGEN TYPE 2; CURCUMA LONGA EXTRACT; CYTOKINE; HERBACEOUS AGENT; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PAEONIA LACTIFLORA EXTRACT; PAEONIA SUFFRUTICOSA EXTRACT; QINFU GUANJIESHU; SINOMENIUM ACUTUM EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACONITUM; ACONITUM CARMICHAELI; ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; CURCUMA LONGA; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MIXTURE; FEMALE; HISTOPATHOLOGY; NONHUMAN; PAEONIA SUFFRUTICOSA; RAT; RHEUMATOID ARTHRITIS; SINOMENIUM; SINOMENIUM ACUTUM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CYTOKINES; DRUGS, CHINESE HERBAL; FEMALE; INFLAMMATION; JOINTS; RATS; RATS, WISTAR; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; BOVINAE; RATTUS; RATTUS NORVEGICUS;

EID: 33846817490     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.09.008     Document Type: Article

References (40)

1. Beehler B.C., Hei Y.J., Chen S., Lupisella J.A., Ostrowski J., Starrett J.E., Tortolani D., Tramposch K.M., and Reczek P.R. Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritis. The Journal of Rheumatology 30 (2003) 355-363
2. Bendele A.M., Chlipala E.S., Scherrer J., Frazier J., Sennello G., Rich W.J., and Edwards C.K. Combination benefit of treatment with the cytokines inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis. Arthritis and Rheumatism 43 (2000) 2648-2659
3. Billingham M.E. Models of arthritis and the search for anti-arthritic drugs. Pharmacology & Therapeutics 21 (1983) 389-428
4. Bisset N.G. Arrow poisons in China Part II aconitum: botany, chemistry and pharmacology. Journal of Ethnopharmacology 4 (1981) 247-336
5. Bull B.S., Caswell M., Ernst E., Kallner A., Koepke J.A., Lewis S.M., Lowe G.D.O., Rampling M.W., and Stuart J. ICSH recommendations for measurement of erythrocyte sedimentation rate. Journal of Clinical Pathology 46 (1993) 198-203
6. Burger D., Rezzonico R., Li J.M., Modoux C., Pierce R.A., Welgus H.G., and Dayer J. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. Arthritis and Rheumatism 41 (1998) 1748-1759
7. Cai X., Zhou H., Wong Y.F., Xie Y., Liu Z.Q., Jiang Z.H., Bian Z.X., Xu H.X., and Liu L. Suppressive effects of QFGJS, a preparation from an anti-arthritic herbal formula, on rat experimental adjuvant-induced arthritis. Biochemical and Biophysical Research Communications 337 (2005) 586-594
8. Chang S.H., Sung H.C., Choi Y., Ko S.Y., Lee B.E., Baek D.H., Kim S.W., and Kim J.K. Suppressive effect of AIF, a water extract from three herbs, on collagen-induced arthritis in mice. International Immunopharmacology 5 (2005) 1365-1372
9. In: Chen J.K., and Chen T.T. (Eds). Chinese Medical Herbology and Pharmacology (2001), Art of Medicine Press Inc., California
10. Chou T.C. Anti-inflammatory and analgesic effects of paeonol in carrageenan-evoked thermal hyperalgesia. British Journal of Pharmacology 139 (2003) 1146-1152
11. Conway J.G., Wakefield J.A., Brown R.H., Marron B.E., Sekut L., Stimpson S.A., McElroy A., Menius J.A., Jeffreys J.J., Clark R.L., McGeehan G.M., and Connolly K.M. Inhition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. Journal of Experimental Medicine 182 (1995) 449-457
12. Feige U., Hu Y.L., Gasser J., Campagnuolo G., Munyakazi L., and Bolon B. Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant-induced arthritis in Lewis rats. Cellular and Molecular Life Sciences 57 (2000) 1457-1470
13. Feldmann M., and Maini R.N. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?. Annual Review of Immunology 19 (2001) 163-196
14. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annual Review of Immunology 14 (1996) 397-440
15. Gabriel S.E. The epidemiology of rheumatoid arthritis. Rheumatic Disease Clinics of North America 27 (2001) 269-282
16. Gravallese E.M., and Goldring S.R. Cellular mechanism and the role of cytokines in bone erosions in rheumatoid arthritis. Arthritis and Rheumatism 43 (2000) 2143-2151
17. Hamada T., Arima N., Shindo M., Sugama K., and Sasaguri Y. Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor. British Journal of Pharmacology 131 (2000) 513-520
18. Hikino H., Konno C., Takata H., Yamada Y., Yamada C., Ohizumi Y., Sugio K., and Fujimura H. Antiinflammatory principles of Aconitum roots. Journal of Pharmacobiodynamics 3 (1980) 514-525
19. Jones G., Halbert J., Crotty M., Shanahan E.M., Batterham M., and Ahern M. The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials. Rheumatology 42 (2003) 6-13
20. Kremer J.M. Methotrexate and leflunomide: biochemical basis for combination therapy in the treatment of rheumatoid arthritis. Seminars in Arthritis and Rheumatism 29 (1999) 14-26
21. Liu L., Resch K., and Kaever V. Inhibition of lymphocyte proliferation by the anti-rheumatic drug sinomenine. International Journal of Immunopharmacology 16 (1994) 685-691
22. Liu L., Buchner E., Beitze D., Schmidt-Weber C.B., Kaever V., Emmrich F., and Kinne R.W. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. International Journal of Immunopharmacology 18 (1996) 529-543
23. Maini R.N., and Taylor P.C. Anti-cytokines therapy for rheumatoid arthritis. Annual Review of Medicine 51 (2000) 207-229
24. McCartney-Francis N.L., Chan J., and Wahl S.M. Inflammatory joint disease: clinical, histological, and molecular parameters of acute and chronic inflammation and tissue destruction. In: Winyard P.G., and Willoughby D.A. (Eds). Inflammation Protocols (2003), Humana Press, New Jersey 147-159
25. Nishikawa M., Myoui A., Tomita T., Takahi K., Nampei A., and Yoshikawa H. Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis and Rheumatism 48 (2003) 2670-2681
26. Park K.C., Park E.J., Kim E.R., Kim Y., Chung S.H., Cho B.W., Kim S., and Jin M. Therapeutic effects of PG201, an ethonal extract from herbs, through cartilage protection on collagenase-induced arthritis in rabbits. Biochemical and Biophysical Research Communications 331 (2005) 1469-1477
27. Pincus T.E., Brooks R.H., and Callahan L.F. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Annals of Intern Medicine 120 (1994) 26-34
28. Rafatullah S., Tariq M., Al-Yahya M.A., Mossa J.S., and Ageel A.M. Evaluation of turmeric (Curcuma longa) for gastric and duodenal antiulcer activity in rats. Journal of Ethnopharmacology 29 (1990) 25-34
29. Rao J.K., Mihaliak K., Kroenke K., Bradley J., Tierney W.M., and Weinberger M. Use of complementary therapies for arthritis among patients of rheumatologists. Annals of Intern Medicine 131 (1999) 409-416
30. Rosloniec E.F., Cremer M., Kang A., and Myers L.K. Animal models for autoimmune and inflammatory disease: collagen-induced arthritis. In: Colagin J.E. (Ed). Current protocols in immunology (1994), John Wiley, New York 1-31 Unit 15.5
31. Shin S.S., Jin M., Jung H.J., Kim B., Jeon H., Choi J.J., Kim J.M., Cho B.W., Chung S.H., and Lee Y.W. Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice. Rheumatology 42 (2003) 665-672
32. Smolen J.S., and Steiner G. Therapeutic strategies for rheumatoid arthritis. Nature Reviews. Drug Discovery 2 (2003) 473-488
33. Soeken K.L., Miller S.A., and Ernst E. Herbal medicines for the treatment of rheumatoid arthritis: a systematic review. Rheumatology 42 (2003) 652-659
34. Suzuki Y., Oyama T., Ishige A., Isono T., Asami A., Ikeda Y., Noguchi M., and Omiya Y. Antinociceptive mechanism of the aconitine alkaloids mesaconitine and benzoylmesaconine. Planta Medica 60 (1994) 391-394
35. Szekanecz Z., Koch A.E., Kunkel S.L., and Strieter R.M. Cytokines in rheumatoid arthritis: potential targets for pharmacological intervention. Drugs and Aging 12 (1998) 377-390
36. Tai Z., and Hopkins S.J. Sinomenine: antiarthritic and anti-inflammatory. Drugs of the Future 23 (1998) 45-49
37. Trentham D.E., Townes A.S., and Kang A.H. Autoimmunity to type II collagen: an experimental model of arthritis. The Journal of Experimental Medicine 146 (1977) 857-868
38. Tsai H.Y., Lin Y.T., Tsai C.H., and Chen Y.F. Effects of paeoniflorin on the formalin-induced nociceptive behaviour in mice. Journal of Ethnopharmacology 25 (2001) 267-271
39. Weyand C.M. New insights into the pathogenesis of rheumatoid arthritis. Rheumatology 39 suppl. 1 (2000) 3-8
40. Zhou H., Wong Y.F., Cai X., Liu Z.Q., Jiang Z.H., Bian Z.X., Xu H.X., and Liu L. Suppressive effects of JCICM-6, the extract of an anti-arthritic herbal formula, on the experimental inflammatory and nociceptive models in rodents. Biological and Pharmaceutical Bulletin 29 (2006) 253-260